1887

Abstract

Dengue virus (DENV) replication is known to prevent maturation of infected dendritic cells (DCs) thereby impeding the development of adequate immunity. During secondary DENV infection, dengue-specific antibodies can suppress DENV replication in immature DCs (immDCs), however how dengue-antibody complexes (DENV-IC) influence the phenotype of DCs remains elusive. Here, we evaluated the maturation state and cytokine profile of immDCs exposed to DENV-ICs. Indeed, DENV infection of immDCs in the absence of antibodies was hallmarked by blunted upregulation of CD83, CD86 and the major histocompatibility complex molecule HLA-DR. In contrast, DENV infection in the presence of neutralizing antibodies triggered full DC maturation and induced a balanced inflammatory cytokine response. Moreover, DENV infection under non-neutralizing conditions prompted upregulation of CD83 and CD86 but not HLA-DR, and triggered production of pro-inflammatory cytokines. The effect of DENV-IC was found to be dependent on the engagement of FcγRIIa. Altogether, our data show that the presence of DENV-IC alters the phenotype and cytokine profile of DCs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000491
2016-07-01
2020-04-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/7/1584.html?itemId=/content/journal/jgv/10.1099/jgv.0.000491&mimeType=html&fmt=ahah

References

  1. Banchereau J., Steinman R. M.. 1998; Dendritic cells and the control of immunity. Nature392:245–252 [CrossRef][PubMed]
    [Google Scholar]
  2. Bhatt S., Gething P. W., Brady O. J., Messina J. P., Farlow A. W., Moyes C. L., Drake J. M., Brownstein J. S., Hoen A. G. et al. 2013; The global distribution and burden of dengue. Nature496:504–507 [CrossRef][PubMed]
    [Google Scholar]
  3. Boonnak K., Dambach K. M., Donofrio G. C., Tassaneetrithep B., Marovich M. A.. 2011; Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol85:1671–1683 [CrossRef][PubMed]
    [Google Scholar]
  4. Boonnak K., Slike B. M., Burgess T. H., Mason R. M., Wu S. J., Sun P., Porter K., Rudiman I. F., Yuwono D. et al. 2008; Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol82:3939–3951 [CrossRef][PubMed]
    [Google Scholar]
  5. Cella M., Sallusto F., Lanzavecchia A.. 1997; Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol9:10–16[PubMed][CrossRef]
    [Google Scholar]
  6. Chang T. H., Chen S. R., Yu C. Y., Lin Y. S., Chen Y. S., Kubota T., Lin Y. L.. 2012; Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-kappaB activation to downregulate cytokine production. PloS One7:e41635[CrossRef]
    [Google Scholar]
  7. Chawla T., Chan K. R., Zhang S. L., Tan H. C., Lim A. P., Hanson B. J., Ooi E. E.. 2013; Dengue virus neutralization in cells expressing Fc gamma receptors. PLoS One8:e65231 [CrossRef][PubMed]
    [Google Scholar]
  8. Costa V. V., Fagundes C. T., Souza D. G., Teixeira M. M.. 2013; Inflammatory and innate immune responses in dengue infection: protection versus disease induction. Am J Pathol182:1950–1961 [CrossRef][PubMed]
    [Google Scholar]
  9. de Alwis R., Beltramello M., Messer W. B., Sukupolvi-Petty S., Wahala W. M., Kraus A., Olivarez N. P., Pham Q., Brien J. D. et al. 2011; In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis5:e1188 [CrossRef][PubMed]
    [Google Scholar]
  10. de Witte L., Abt M., Schneider-Schaulies S., van Kooyk Y., Geijtenbeek T. B.. 2006; Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol80:3477–3486 [CrossRef][PubMed]
    [Google Scholar]
  11. Dejnirattisai W., Webb A. I., Chan V., Jumnainsong A., Davidson A., Mongkolsapaya J., Screaton G.. 2011; Lectin switching during dengue virus infection. J Infect Dis203:1775–1783 [CrossRef][PubMed]
    [Google Scholar]
  12. den Dunnen J., Vogelpoel L. T., Wypych T., Muller F. J., de Boer L., Kuijpers T. W., Zaat S. A., Kapsenberg M. L., de Jong E. C.. 2012; IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcγRIIa in human dendritic cells. Blood120:112–121 [CrossRef][PubMed]
    [Google Scholar]
  13. Dudek A. M., Martin S., Garg A. D., Agostinis P.. 2013; Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol4:438 [CrossRef][PubMed]
    [Google Scholar]
  14. Endy T. P., Nisalak A., Chunsuttitwat S., Vaughn D. W., Green S., Ennis F. A., Rothman A. L., Libraty D. H.. 2004; Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis189:990–1000 [CrossRef][PubMed]
    [Google Scholar]
  15. Green S., Rothman A.. 2006; Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis19:429–436 [CrossRef][PubMed]
    [Google Scholar]
  16. Gudmundsson G., Bosch A., Davidson B. L., Berg D. J., Hunninghake G. W.. 1998; Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol19:812–818 [CrossRef][PubMed]
    [Google Scholar]
  17. Halstead S. B.. 2003; Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res60:421–467[PubMed][CrossRef]
    [Google Scholar]
  18. Halstead S. B.. 2007; Dengue. Lancet370:1644–1652 [CrossRef][PubMed]
    [Google Scholar]
  19. Hause A. M., Perez-Padilla J., Horiuchi K., Han G. S., Hunsperger E., Aiwazian J., Margolis H. S., Tomashek K. M.. 2015; Epidemiology of dengue among children aged < 18 months-Puerto Rico, 1999–2011. Am J Trop Med Hyg94:404–408 [CrossRef][PubMed]
    [Google Scholar]
  20. Ho L. J., Wang J. J., Shaio M. F., Kao C. L., Chang D. M., Han S. W., Lai J. H.. 2001; Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol166:1499–1506[PubMed][CrossRef]
    [Google Scholar]
  21. Kliks S. C., Nimmanitya S., Nisalak A., Burke D. S.. 1988; Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg38:411–419[PubMed]
    [Google Scholar]
  22. Libraty D. H., Pichyangkul S., Ajariyakhajorn C., Endy T. P., Ennis F. A.. 2001; Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol75:3501–3508 [CrossRef][PubMed]
    [Google Scholar]
  23. Lilley B. N., Ploegh H. L.. 2005; Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev207:126–144 [CrossRef][PubMed]
    [Google Scholar]
  24. Liu L., Chavan R., Feinberg M. B.. 2008; Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunology9:15 [CrossRef][PubMed]
    [Google Scholar]
  25. Lutz M. B., Schuler G.. 2002; Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol23:445–449 [CrossRef][PubMed]
    [Google Scholar]
  26. Mangada M. M., Rothman A. L.. 2005; Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol175:2676–2683[PubMed][CrossRef]
    [Google Scholar]
  27. Marovich M., Grouard-Vogel G., Louder M., Eller M., Sun W., Wu S. J., Putvatana R., Murphy G., Tassaneetrithep B. et al. 2001; Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc6:219–224 [CrossRef][PubMed]
    [Google Scholar]
  28. Mathew A., Kurane I., Green S., Vaughn D. W., Kalayanarooj S., Suntayakorn S., Ennis F. A., Rothman A. L.. 1999; Impaired T cell proliferation in acute dengue infection. J Immunol162:5609–5615
    [Google Scholar]
  29. Miller R. L., Meng T. C., Tomai M. A.. 2008; The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect21:69–87 [CrossRef][PubMed]
    [Google Scholar]
  30. Modhiran N., Kalayanarooj S., Ubol S.. 2010; Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis4:e924 [CrossRef][PubMed]
    [Google Scholar]
  31. Moi M. L., Lim C. K., Takasaki T., Kurane I.. 2010; Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol91:103–111 [CrossRef][PubMed]
    [Google Scholar]
  32. Muñoz-Jordan J. L., Sánchez-Burgos G. G., Laurent-Rolle M., García-Sastre A.. 2003; Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A100:14333–14338 [CrossRef][PubMed]
    [Google Scholar]
  33. Muñoz-Jordán J. L.. 2010; Subversion of interferon by dengue virus. Curr Top Microbiol Immunol338:35–44 [CrossRef][PubMed]
    [Google Scholar]
  34. Navarro-Sánchez E., Desprès P., Cedillo-Barrón L.. 2005; Innate immune responses to dengue virus. Arch Med Res36:425–435 [CrossRef][PubMed]
    [Google Scholar]
  35. Nightingale Z. D., Patkar C., Rothman A. L.. 2008; Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol84:1028–1038 [CrossRef][PubMed]
    [Google Scholar]
  36. Nimmerjahn F., Ravetch J. V.. 2008; Fcgamma receptors as regulators of immune responses. Nat Rev Immunol8:34–47 [CrossRef][PubMed]
    [Google Scholar]
  37. Oreshkova N., Wichgers Schreur P. J., Spel L., Vloet R. P., Moormann R. J., Boes M., Kortekaas J.. 2015; Nonspreading Rift Valley fever virus infection of human dendritic cells results in downregulation of CD83 and full maturation of bystander cells. PLoS One10:e0142670 [CrossRef][PubMed]
    [Google Scholar]
  38. Palmer D. R., Sun P., Celluzzi C., Bisbing J., Pang S., Sun W., Marovich M. A., Burgess T.. 2005; Differential effects of dengue virus on infected and bystander dendritic cells. J Virol79:2432–2439 [CrossRef][PubMed]
    [Google Scholar]
  39. Pang T., Cardosa M. J., Guzman M. G.. 2007; Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol85:43–45 [CrossRef][PubMed]
    [Google Scholar]
  40. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Théry C., Rescigno M., Saito T., Verbeek S., Bonnerot C. et al. 1999; Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med189:371–380[PubMed][CrossRef]
    [Google Scholar]
  41. Reich N. G., Shrestha S., King A. A., Rohani P., Lessler J., Kalayanarooj S., Yoon I. K., Gibbons R. V., Burke D. S., Cummings D. A.. 2013; Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J R Soc Interface10:20130414 [CrossRef][PubMed]
    [Google Scholar]
  42. Richter M. K. S., da Silva Voorham J. M., Torres Pedraza S., Hoornweg T. E., van de Pol D. P. I., Rodenhuis-Zybert I. A., Wilschut J., Smit J. M.. 2014; Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. PLoS ONE9:e98785 [CrossRef]
    [Google Scholar]
  43. Rinaldo C. R.. 2013; HIV-1 trans infection of CD4(+) T cells by professional antigen presenting cells. Scientifica (Cairo)2013:164203 [CrossRef][PubMed]
    [Google Scholar]
  44. Rodenhuis-Zybert I. A., van der Schaar H. M., da Silva Voorham J. M., van der Ende-Metselaar H., Lei H. Y., Wilschut J., Smit J. M.. 2010; Immature dengue virus: a veiled pathogen?. PLoS Pathog6:e1000718 [CrossRef][PubMed]
    [Google Scholar]
  45. Rodrigo W. W., Jin X., Blackley S. D., Rose R. C., Schlesinger J. J.. 2006; Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J Virol80:10128–10138 [CrossRef][PubMed]
    [Google Scholar]
  46. Rodriguez-Madoz J. R., Belicha-Villanueva A., Bernal-Rubio D., Ashour J., Ayllon J., Fernandez-Sesma A.. 2010a; Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol84:9760–9774 [CrossRef][PubMed]
    [Google Scholar]
  47. Rodriguez-Madoz J. R., Bernal-Rubio D., Kaminski D., Boyd K., Fernandez-Sesma A.. 2010b; Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol84:4845–4850 [CrossRef][PubMed]
    [Google Scholar]
  48. Rothman A. L.. 2011; Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol11:532–543 [CrossRef][PubMed]
    [Google Scholar]
  49. Sanchez V., Hessler C., DeMonfort A., Lang J., Guy B.. 2006; Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain. FEMS Immunol Med Microbiol46:113–123 [CrossRef][PubMed]
    [Google Scholar]
  50. Schmid M. A., Harris E.. 2014; Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog10:e1004541 [CrossRef][PubMed]
    [Google Scholar]
  51. Schuurhuis D. H., van Montfoort N., Ioan-Facsinay A., Jiawan R., Camps M., Nouta J., Melief C. J., Verbeek J. S., Ossendorp F.. 2006; Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol176:4573–4580[PubMed][CrossRef]
    [Google Scholar]
  52. Simmons C. P., Chau T. N., Thuy T. T., Tuan N. M., Hoang D. M., Thien N. T., Lien le B., Quy N. T., Hieu N. T. et al. 2007; Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis196:416–424 [CrossRef][PubMed]
    [Google Scholar]
  53. Soundravally R., Hoti S. L., Patil S. A., Cleetus C. C., Zachariah B., Kadhiravan T., Narayanan P., Kumar B. A.. 2014; Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. Int J Infect Dis18:68–72 [CrossRef][PubMed]
    [Google Scholar]
  54. Sun P., Fernandez S., Marovich M. A., Palmer D. R., Celluzzi C. M., Boonnak K., Liang Z., Subramanian H., Porter K. R. et al. 2009; Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology383:207–215 [CrossRef][PubMed]
    [Google Scholar]
  55. van der Poll T., Marchant A., Buurman W. A., Berman L., Keogh C. V., Lazarus D. D., Nguyen L., Goldman M., Moldawer L. L., Lowry S. F.. 1995; Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol155:5397–5401[PubMed]
    [Google Scholar]
  56. van der Schaar H. M., Rust M. J., Chen C., van der Ende-Metselaar H., Wilschut J., Zhuang X., Smit J. M.. 2008; Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog4:e1000244 [CrossRef][PubMed]
    [Google Scholar]
  57. van der Schaar H. M., Rust M. J., Waarts B. L., van der Ende-Metselaar H., Kuhn R. J., Wilschut J., Zhuang X., Smit J. M.. 2007; Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol81:12019–12028 [CrossRef][PubMed]
    [Google Scholar]
  58. van der Schaar H. M., Wilschut J. C., Smit J. M.. 2009; Role of antibodies in controlling dengue virus infection. Immunobiology214:613–629 [CrossRef][PubMed]
    [Google Scholar]
  59. Vogelpoel L. T., Hansen I. S., Rispens T., Muller F. J., van Capel T. M., Turina M. C., Vos J. B., Baeten D. L., Kapsenberg M. L. et al. 2014; Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun5:5444 [CrossRef][PubMed]
    [Google Scholar]
  60. WHO 1997;Dengue hemorrhagic fever: diagnosis, treatment, prevention and control world health organization;
    [Google Scholar]
  61. Wu S. J., Grouard-Vogel G., Sun W., Mascola J. R., Brachtel E., Putvatana R., Louder M. K., Filgueira L., Marovich M. A. et al. 2000; Human skin Langerhans cells are targets of dengue virus infection. Nat Med6:816–820 [CrossRef][PubMed]
    [Google Scholar]
  62. Yao Y., Li W., Kaplan M. H., Chang C. H.. 2005; Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med201:1899–1903 [CrossRef][PubMed]
    [Google Scholar]
  63. Zybert I. A., van der Ende-Metselaar H., Wilschut J., Smit J. M.. 2008; Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol89:3047–3051 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000491
Loading
/content/journal/jgv/10.1099/jgv.0.000491
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error